CONTRACT OPPORTUNITY

FDA researches info system modernization

The Federal Drug Administration is developing a web-based electronic system to store criminal information and conduct administrative functions.

The FDA has launched its Automated Investigative Management System (AIMS) Modernization program. The agency released a draft statement of work April 16 as it researches industry for software and services solutions to set up the system.

The FDA’s Office of Criminal Investigations conducts resource-intensive investigations that expand globally and plays a role in protecting the public health from violators.

The new system should include a decision-making tool to conduct trend analyses, enhance reporting and case management, and provide for automated business processes and workflows. Working with criminal activity information, the FDA wants enhanced security protocols, and a process management workflow capability to improve field operations, reporting, and data management.

Response deadline is April 24.

About the Author

Matthew Weigelt is a freelance journalist who writes about acquisition and procurement.

Reader Comments

Please post your comments here. Comments are moderated, so they may not appear immediately after submitting. We will not post comments that we consider abusive or off-topic.

Please type the letters/numbers you see above

What is your e-mail address?

My e-mail address is:

Do you have a password?

Forgot your password? Click here
close

Trending

  • POWER TRAINING: How to engage your customers

    Don't miss our Aug. 2 Washington Technology Power Training session on Mastering Stakeholder Engagement, where you'll learned the critical skills you need to more fully connect with your customers and win more business. Read More

  • PROJECT 38 PODCAST

    In our latest Project 38 Podcast, editor Nick Wakeman interviews Tom Romeo, the leader of Maximus Federal about how it has zoomed up the 2019 Top 100. Read More

contracts DB

Washington Technology Daily

Sign up for our newsletter.

Terms and Privacy Policy consent

I agree to this site's Privacy Policy.